Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 30551-30600 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05993390
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
NA
Recruiting
30 participants
Started: Jan 11, 2024 · Completed: Aug 30, 2025
3 conditions
1 sponsor
1 location
NCT06127797
Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue
N/A
Recruiting
1,000 participants
Started: Jan 11, 2024 · Completed: Aug 31, 2029
1 condition
1 sponsor
1 location
NCT06644248
AI Model for Cervical Cancer Detection From Colposcopy Images
N/A
Recruiting
500 participants
Started: Jan 11, 2024 · Completed: Feb 11, 2025
1 condition
1 sponsor
1 location
NCT05035342
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
PHASE3
Recruiting
214 participants
Started: Jan 11, 2024 · Completed: Apr 30, 2028
2 conditions
1 sponsor
11 locations
NCT06077422
Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
PHASE2/PHASE3
Recruiting
120 participants
Started: Jan 11, 2024 · Completed: Apr 5, 2025
4 conditions
2 sponsors
1 location
NCT07004517
The Study on the Accuracy of Peri-implant Probing and Related Influencing Factors
N/A
Recruiting
83 participants
Started: Jan 11, 2024 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT06564415
European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms
N/A
Recruiting
2,500 participants
Started: Jan 11, 2024 · Completed: Jan 31, 2034
2 conditions
1 sponsor
1 location
NCT06027294
Blood Flow Regulation and Neuromuscular Function Post-Stroke
NA
Recruiting
40 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2028
1 condition
1 sponsor
2 locations
NCT06391892
Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
PHASE3
Recruiting
100 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT06208215
RZ358 Treatment for Congenital Hyperinsulinism
PHASE3
Recruiting
56 participants
Started: Jan 11, 2024 · Completed: Sep 28, 2026
1 condition
1 sponsor
24 locations
NCT06157502
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
PHASE3
Recruiting
1,380 participants
Started: Jan 11, 2024 · Completed: Jul 31, 2026
1 condition
1 sponsor
82 locations
NCT06469424
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
N/A
Recruiting
104 participants
Started: Jan 11, 2024 · Completed: Mar 31, 2026
1 condition
2 sponsors
5 locations
NCT06717984
AI Model for Classifying Breast Cancer From Histopathology Images
N/A
Recruiting
500 participants
Started: Jan 11, 2024 · Completed: Feb 11, 2025
1 condition
2 sponsors
1 location
NCT06259227
Cardiorespiratory Fitness Training in Patients with Incomplete Spinal Cord Injury
NA
Recruiting
32 participants
Started: Jan 11, 2024 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT06194981
Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage
N/A
Recruiting
260 participants
Started: Jan 11, 2024 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT06418126
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NA
Recruiting
15 participants
Started: Jan 11, 2024 · Completed: Apr 1, 2027
1 condition
2 sponsors
1 location
NCT06074068
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
NA
Recruiting
1,080 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2028
2 conditions
4 sponsors
2 locations
NCT05906992
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
PHASE3
Recruiting
512 participants
Started: Jan 11, 2024 · Completed: Jan 31, 2029
1 condition
1 sponsor
1 location
NCT06396663
DE-eSCALation of Opioids Post-surgical dischargE
NA
Recruiting
100 participants
Started: Jan 11, 2024 · Completed: Sep 30, 2024
1 condition
3 sponsors
1 location
NCT06270199
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
PHASE2
Recruiting
75 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT05573490
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
NA
Recruiting
60 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2028
1 condition
5 sponsors
1 location
NCT06051227
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
PHASE3
Recruiting
608 participants
Started: Jan 11, 2024 · Completed: Mar 31, 2026
5 conditions
3 sponsors
1 location
NCT06214143
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
68 participants
Started: Jan 11, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
22 locations
NCT06146257
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
PHASE1
Recruiting
48 participants
Started: Jan 11, 2024 · Completed: Oct 8, 2026
2 conditions
1 sponsor
8 locations
NCT06231641
The Effects of Lemborexant on the Ability to Sleep During Daytime
PHASE2
Recruiting
24 participants
Started: Jan 11, 2024 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT06220617
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
N/A
Recruiting
3,600 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2027
4 conditions
2 sponsors
6 locations
NCT05975593
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
NA
Recruiting
60 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2032
10 conditions
2 sponsors
1 location
NCT06109272
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
PHASE2/PHASE3
Recruiting
660 participants
Started: Jan 11, 2024 · Completed: Sep 30, 2030
1 condition
1 sponsor
37 locations
NCT06042699
Kids With Iron Deficiency and Scoliosis
NA
Recruiting
275 participants
Started: Jan 11, 2024 · Completed: Feb 1, 2028
7 conditions
2 sponsors
1 location
NCT06321939
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
N/A
Recruiting
50 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT06479057
PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy
N/A
Recruiting
210 participants
Started: Jan 11, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06706557
Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
N/A
Recruiting
30 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT05780905
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
PHASE4
Recruiting
50 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06155396
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
PHASE2
Recruiting
116 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
12 locations
NCT06182644
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
NA
Recruiting
30 participants
Started: Jan 11, 2024 · Completed: Sep 1, 2025
6 conditions
1 sponsor
1 location
NCT06924099
TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
N/A
Recruiting
430 participants
Started: Jan 11, 2024 · Completed: Jan 31, 2029
1 condition
1 sponsor
24 locations
NCT06386497
Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
NA
Recruiting
15 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT06208410
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
PHASE1/PHASE2
Recruiting
306 participants
Started: Jan 11, 2024 · Completed: Feb 26, 2027
1 condition
1 sponsor
1 location
NCT06896344
Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells
N/A
Recruiting
10 participants
Started: Jan 11, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06223646
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
29 participants
Started: Jan 11, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06055296
Multisite Implementation of COMPRENDO
NA
Recruiting
450 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2028
1 condition
5 sponsors
4 locations
NCT06190301
RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma
NA
Recruiting
108 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2029
1 condition
1 sponsor
2 locations
NCT05995717
Evaluation of PKU UP
NA
Recruiting
15 participants
Started: Jan 11, 2024 · Completed: May 31, 2026
1 condition
2 sponsors
7 locations
NCT06064877
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
PHASE3
Recruiting
410 participants
Started: Jan 11, 2024 · Completed: Nov 30, 2027
2 conditions
1 sponsor
110 locations
NCT05923086
Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy.
PHASE2
Recruiting
126 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT06199401
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
NA
Recruiting
680 participants
Started: Jan 11, 2024 · Completed: Dec 1, 2027
3 conditions
4 sponsors
1 location
NCT06219356
A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
PHASE1
Recruiting
110 participants
Started: Jan 11, 2024 · Completed: Feb 28, 2027
1 condition
1 sponsor
13 locations
NCT06399614
Occupational Therapy-led Services for Adults Presenting Acutely With a Hand Condition
N/A
Recruiting
150 participants
Started: Jan 11, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
5 locations
NCT06149130
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer
PHASE2
Recruiting
82 participants
Started: Jan 11, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT06364995
Effects of Specialised Physical Education in Volleyball on Middle School Students' Physical Fitness and Performance
NA
Recruiting
90 participants
Started: Jan 10, 2024 · Completed: Jul 5, 2024
2 conditions
1 sponsor
1 location
Previous
1
More pages
609
610
611
612
613
614
615
More pages
1333
Next